-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMIX BIOPHARMA ANNOUNCES ACCELERATED NEXICART-2 CLINICAL TRIAL PROGRESS IN RELAPSED/REFRACTORY AL AMYLOIDOSIS

Reuters·07/07/2025 13:35:00

Please log in to view news